Bausch Health Companies (BHC) Return on Sales (2009 - 2026)

Bausch Health Companies has disclosed Return on Sales across 18 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.01% for Q1 2026 at Bausch Health Companies, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2022 to a low of 0.01% in Q1 2026.
• The 5-year median for Return on Sales is 0.0% (2024), against an average of 0.0%.
• Across the five-year window, Return on Sales changed 0 bps in 2022 and fell 1 bps in 2026, its largest moves.
• Bausch Health Companies' Return on Sales stood at 0.0% in 2022, then soared by 90 bps to 0.0% in 2023, then soared by 296 bps to 0.0% in 2024, then tumbled by 196 bps to 0.0% in 2025, then plunged by 1439 bps to 0.01% in 2026.
• The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.